A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results